Meta-analysia of combining rh-endostatin with chemotherapy in treatment of patients with nsclc
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: CHEN, Baicheng (The 303 Hospital of PLA, China, Nanning, China)
- Co-author(s): Zhang, Qi (The 303 Hospital of PLA, China, NANNING, China)
Xia, Aijun (The 303 Hospital of PLA, China, NANNING, China)
Objective In order to evaluate the efficacy of combining rh-endostatin with Chemo- therapy for non-small cell lung cancer(NSCLC) compared with chemotherapy alone. Methods The randomized clinical trials(RCTs) that compared the efficacy of combining rh-endostatin with Chemotherapy and chemotherapy alone form 2000 to 2004. A meta-analysis was.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.